Browse News
Filter News
Found 375 articles
-
Cell Dissociation Market Hit Robust Growth 13.92% by 2033
4/23/2024
The global cell dissociation market size was evaluated at US$ 550 million in 2023 and is expected to attain around US$ 2,003 million by 2033, growing at a CAGR of 13.92% from 2024 to 2033.
-
Single-use Bioprocessing Market Size to Increase USD 128.24 Bn by 2033
4/9/2024
According to Nova One Advisor, the global single-use bioprocessing market size was estimated at USD 28.45 billion in 2023 and it is projected to increase USD 128.24 billion by 2033 with a CAGR of 16.25% from 2024 to 2033.
-
Cytomos appoints new Chief Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves from an R&D to a product-based business
1/23/2024
Cytomos (www.cytomotos.com) is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge
-
Biotechnology Instruments Market Size To Hold USD 128.4 Billion By 2032
12/19/2023
The global biotechnology instruments market size was exhibited at USD 87.16 billion in 2022 and it is expected to hold around USD 128.4 billion by 2032, growing at a CAGR of 3.95% from 2023 to 2032.
-
Process Chromatography Market Size to Surpass USD 27.87 Billion By 2032
11/17/2023
The global process chromatography market size was valued at USD 12.5 billion in 2022 and is projected to surpass around USD 27.87 billion by 2032, expanding at a healthy CAGR of 8.4% from 2023 to 2032.
-
Single-use Bioprocessing Market to Worth USD 84,140 Million by 2032
8/22/2023
The global single-use bioprocessing market reached a value of USD 20,960 million in 2022 and is projected to be worth around USD 84,140 million by 2032, experiencing a compound annual growth rate (CAGR) of 15.46% from 2023 to 2032.
-
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
8/17/2023
Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.
-
Abcam plc files and mails Shareholder Circular calling an Extraordinary General Meeting
6/16/2023
Abcam plc, a global leader in the supply of life science research tools, filed and mailed a shareholder circular calling an Extraordinary General Meeting to be held on July 12, 2023 at 2:00pm || 9:00am.
-
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
6/5/2023
Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.
-
Cell Line Development Market to Hit 13.3% CAGR to 2027 Led by Media and Reagent Segment - The Insight Partners
4/18/2023
The Insight Partners published latest research report on "Cell Line Development Market Share Report, Size, Analysis, Statistics, Trends & Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Product, Application and Geography,"
-
Sartorius to Host 2023 Sartorius Summit Event
3/16/2023
Event will feature industry leaders, cutting-edge technology in cell line development CAMBRIDGE-March 16, 2023- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will host the Sartorius Summit:
-
Preliminary results 2022 of Sartorius Stedim Biotech
1/26/2023
Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.
-
Sartorius with clear double-digit growth in fiscal 2022
1/26/2023
Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability.
-
Sartorius names Maurice Phelan as new President for North America
1/3/2023
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has announced Maurice Phelan has assumed the role of President of Sartorius North America.
-
Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First Next-Generation Single-Molecule Protein Sequencing Platform
12/20/2022
Quantum-Si Announces Commercial Availability of Platinum TM , the World’s First Next-Generation Single-Molecule Protein Sequencing Platform.
-
Bioprocess Technology Market Size to Hit USD 53.30 Bn by 2030
12/7/2022
According to Nova one advisor, the global Bioprocess Technology market size is expected to hit around USD 53.30 billion by 2030 from valued at USD 23.45 billion in 2021 and growing at a CAGR of 9.7% from 2022 to 2030.
-
Antibody Production Market Size up to 2030 - Quantitative Research by QYResearch Medical
11/17/2022
The global antibody production market size is expected to reach USD 37.81 Billion in 2030 and register a revenue CAGR of 14.4% during the forecast period.
-
Downstream Processing Market Size - Quantitative Research By QYResearch Medical
11/15/2022
The global downstream processing market is forecasted to grow at a rate of 12.7%, from USD 18.22 billion in 2019 to USD 45.49 billion in 2030.
-
Microcarrier Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical
11/14/2022
The microcarrier market size was USD 1.4 Billion in 2020 and is expected to register a CAGR of 10.5% during the forecast period.
-
Sartorius successfully places Schuldschein loans with a volume of 650 million euros
11/11/2022
In a challenging market environment, the life science group Sartorius successfully placed Schuldschein loans with a volume of 650 million euros.